The "pUb-R" nomenclature suggests a connection to protein ubiquitination, a post-translational modification in which a ubiquitin molecule is added to a protein. Ubiquitination plays a role in regulating protein degradation, signaling, trafficking, and activity. "R" might refer to a specific receptor or regulatory protein associated with this process. Activators of such a system would presumably increase or modulate the activity of the pUb-R protein or pathway, either by directly binding to and activating the protein or by modulating the upstream or downstream components of the pathway.
Chemical activators of protein pathways, in general, are small molecules that can increase or initiate a biological response. They do so either by mimicking the action of the natural ligand or by influencing the conformation of the target protein in a way that promotes its activity. In the case of pUb-R activators, these compounds would be specifically tailored to modulate the ubiquitination process associated with the pUb-R protein or pathway. Given the diverse roles ubiquitination plays in cellular processes, such activators might impact a variety of biological outcomes, from protein degradation rates to intracellular signaling dynamics.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Another antidiabetic drug that targets PPAR-γ. | ||||||
Troglitazone | 97322-87-7 | sc-200904 sc-200904B sc-200904A | 5 mg 10 mg 25 mg | $110.00 $204.00 $435.00 | 9 | |
An earlier member of the thiazolidinedione class, which was removed from the market due to hepatotoxicity. It activates PPAR-γ. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
A fibrate drug that activates all three PPAR subtypes (PPAR-α, PPAR-δ, and PPAR-γ). It's mainly used for the treatment of dyslipidemia. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
A fibrate that activates PPAR-α and is also used to treat hyperlipidemia. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
A PPAR-δ agonist. Originally developed for metabolic and cardiovascular diseases, it's also known for improving endurance, but its long-term safety is controversial. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
A synthetic PPAR-α agonist. It's mainly used in research settings to activate PPAR-α. | ||||||
L-165041 | 79558-09-1 | sc-203094 | 5 mg | $156.00 | ||
A selective PPAR-δ agonist. It's predominantly used in research. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
A monounsaturated fat that has been shown to activate PPAR-α. | ||||||
Linoleic Acid | 60-33-3 | sc-200788 sc-200788A sc-200788B sc-200788C | 100 mg 1 g 5 g 25 g | $34.00 $64.00 $166.00 $281.00 | 4 | |
An essential fatty acid that can activate both PPAR-α and PPAR-γ. | ||||||